FTRE
Price
$15.82
Change
-$0.43 (-2.65%)
Updated
Feb 4, 02:46 PM (EDT)
Capitalization
1.5B
22 days until earnings call
Intraday BUY SELL Signals
JAZZ
Price
$166.44
Change
-$0.41 (-0.25%)
Updated
Feb 4, 02:51 PM (EDT)
Capitalization
10.14B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FTRE vs JAZZ

Header iconFTRE vs JAZZ Comparison
Open Charts FTRE vs JAZZBanner chart's image
Fortrea Holdings
Price$15.82
Change-$0.43 (-2.65%)
Volume$1.99K
Capitalization1.5B
Jazz Pharmaceuticals
Price$166.44
Change-$0.41 (-0.25%)
Volume$200
Capitalization10.14B
FTRE vs JAZZ Comparison Chart in %
FTRE
Daily Signal:
Gain/Loss:
JAZZ
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FTRE vs. JAZZ commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and JAZZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (FTRE: $16.25 vs. JAZZ: $166.84)
Brand notoriety: FTRE and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 120% vs. JAZZ: 44%
Market capitalization -- FTRE: $1.5B vs. JAZZ: $10.14B
FTRE [@Biotechnology] is valued at $1.5B. JAZZ’s [@Biotechnology] market capitalization is $10.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 5 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • FTRE’s TA Score: 5 bullish, 3 bearish.
  • JAZZ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than JAZZ.

Price Growth

FTRE (@Biotechnology) experienced а -5.08% price change this week, while JAZZ (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

FTRE is expected to report earnings on Feb 26, 2026.

JAZZ is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($10.1B) has a higher market cap than FTRE($1.5B). JAZZ YTD gains are higher at: -1.859 vs. FTRE (-5.797). JAZZ has higher annual earnings (EBITDA): 183M vs. FTRE (-852.7M). JAZZ has more cash in the bank: 2.05B vs. FTRE (131M). FTRE has less debt than JAZZ: FTRE (1.19B) vs JAZZ (5.43B). JAZZ has higher revenues than FTRE: JAZZ (4.16B) vs FTRE (2.76B).
FTREJAZZFTRE / JAZZ
Capitalization1.5B10.1B15%
EBITDA-852.7M183M-466%
Gain YTD-5.797-1.859312%
P/E RatioN/A15.38-
Revenue2.76B4.16B66%
Total Cash131M2.05B6%
Total Debt1.19B5.43B22%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREJAZZ
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 3 days ago
59%
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
Bearish Trend 7 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signal:
Gain/Loss:
JAZZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIVP26.630.27
+1.01%
Cullen Enhanced Equity Income ETF
XSLV48.61-0.01
-0.01%
Invesco S&P SmallCap Low Volatility ETF
GUMI50.33-0.02
-0.04%
Goldman Sachs Ultra Shrt Muncpl Inc ETF
LODI25.37-0.01
-0.04%
AAM SLC Low Duration Income ETF
SEIV42.51-0.19
-0.44%
SEI Enhanced US Large Cap Value Fac ETF

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with TECH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-3.62%
TECH - FTRE
42%
Loosely correlated
-0.95%
ALGS - FTRE
41%
Loosely correlated
-5.41%
NTLA - FTRE
41%
Loosely correlated
-0.08%
SYRE - FTRE
40%
Loosely correlated
+1.65%
XNCR - FTRE
40%
Loosely correlated
-0.99%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with BMRN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
-0.27%
BMRN - JAZZ
45%
Loosely correlated
-0.59%
AMLX - JAZZ
43%
Loosely correlated
-1.23%
TECH - JAZZ
43%
Loosely correlated
-0.95%
FTRE - JAZZ
41%
Loosely correlated
-3.62%
XNCR - JAZZ
38%
Loosely correlated
-0.99%
More